NMI bladder cancer, EGF-R, intravesical therapy. fibronectin
Serretta, V., Alonge, V., Carità, G., Scalici Gesolfo, C., Caruso, S., Fiorentino, E., et al. (2014). Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC). In Eur Urology Supplements (pp.409-409). Elsevier Science Limited.
Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)
SERRETTA, Vincenzo;FIORENTINO, Eugenio;RUSSO, Antonio;
2014-01-01
Abstract
NMI bladder cancer, EGF-R, intravesical therapy. fibronectin
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
EAU_14_409.pdf
Solo gestori archvio
Descrizione: abstract
Dimensione
89.26 kB
Formato
Adobe PDF
|
89.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
